because nonsteroidal anti-inflammatory drugs block prostacyclin production and may also shift arachidonic acid into the lipoxygenase pathway , we have evaluated a selective tx synthetase inhibitor ( oky 1581 ) as a means for preventing endotoxin-induced pulmonary hypertension .
C0033567
prostacyclin
C0020542
pulmonary hypertension